Publications
Publications
Show Results For
- All HBS Web
(10,707)
- Faculty Publications (2,641)
- September–October 2023
- Article
The New Era of Industrial Policy Is Here
By: Willy C. Shih
Governments around the world are increasingly intervening in the private sector through industrial policies designed to help domestic sectors reach goals that markets alone are unlikely to achieve. Companies in targeted sectors—such as automakers, energy companies, and... View Details
- September–October 2023
- Article
What Does 'Stakeholder Capitalism' Mean to You?: A Guide to the Four Main Types
By: Lynn S. Paine
Business leaders are being urged to adopt a multistakeholder approach to governance in place of the shareholder-centered approach that has guided their work for several decades. But through hundreds of interviews with directors, executives, investors, governance... View Details
- October 2023
- Article
What Does the Inflation Reduction Act Mean for Patients and Physicians?
By: Amitabh Chandra and Benedic Ippolito
The debate around prescription drug measures in the recently passed U.S. Inflation Reduction Act (IRA), which limit some patients’ out-of-pocket costs, has not fully addressed their effect on physicians and patients via their effect on payers. Reducing patients’ costs... View Details
- August 2023
- Supplement
Apple: Privacy vs. Safety (C)
By: Henry McGee, Nien-hê Hsieh and Kerry Herman
In September 2021, Apple decided to delay updates to iOS and iPadOS that included features to fight child sexual abuse. While many—including prominent privacy and security experts—praised Apple, others were opposed. They saw Apple introducing features that risked... View Details
- August 2023
- Case
Ripple 2023
By: David B. Yoffie, Andy Wu and Sarah von Bargen
This case covers Ripple’s events from 2020–2023. The focus of this case is Ripple’s 2023 victory over the SEC, which sued Ripple in 2020 claiming that they did not register their XRP coins as securities. After Ripple’s victory, CEO Garlinghouse faced numerous... View Details
- August 2023 (Revised May 2024)
- Case
Dicerna Pharmaceuticals: Decision Making in Clinical Trial Design and Operations
By: Satish Tadikonda and Amanda McEwen
The success or failure of Dicerna Pharmaceuticals (Dicerna) as an emerging pharmaceutical company would likely hinge on its lead drug candidate Nedosiran and the company’s ability to see it successfully through clinical development. Ralf Rosskamp, Chief Medical... View Details
- August 2023
- Teaching Note
Kunshan, Incorporated: The Making of China’s Richest Town
By: William C. Kirby and Noah B. Truwit
Teaching Note for HBS Case No. 313-103. The case is designed to give the students an understanding of the local Chinese entrepreneurial state and how foreign and Chinese firms have worked with it to create China’s richest small city. The major themes are—local state... View Details
- August 2023
- Teaching Note
Huawei: A Global Tech Giant in the Crossfire of a Digital Cold War
By: William C. Kirby and Noah B. Truwit
Teaching Note for HBS Case No. 320-089. By 2020, Ren Zhengfei, CEO of Huawei, had transformed the small telephone switch manufacturer he founded in 1987 into a $120 billion telecommunications company poised to lead the lucrative rollout of fifth-generation (5G)... View Details
- August 10, 2023
- Editorial
A Conversation on the Draft Merger Guidelines
By: Cory S. Capps and Leemore Dafny
- August 2023 (Revised October 2023)
- Case
Beyond the Barricades: Chile 2023
Chile, often considered among Latin America's greatest economic success stories, suffered a shocking wave of protests in October 2019, as its citizens demanded reforms across healthcare and education systems, and protested inequality and rising costs of living. As... View Details
- 2023
- Working Paper
Corporate Leaders Say They Are for Stakeholder Capitalism—But Which Version Exactly?: A Critical Look at Four Varieties
By: Lynn S. Paine
The past few years have seen an outpouring of articles and statements heralding the
arrival of a new and more inclusive form of capitalism often called stakeholder capitalism. The
new capitalism promises to strengthen companies, improve outcomes for their... View Details
- 2023
- Book
Precarious Ties: Business and the State in Authoritarian Asia
By: Meg Rithmire
Developing Asia has been the site of some of the last century's fastest growing economies as well as some of the world's most durable authoritarian regimes. Many accounts of rapid growth alongside monopolies on political power have focused on crony relationships... View Details
- 2025
- Working Paper
Residential Battery Storage - Reshaping the Way We Do Electricity
By: Christian Kaps and Serguei Netessine
In this paper, we aim to understand when private households invest in behind-the-meter battery storage next to rooftop solar and how those batteries impact households, the electricity market, and emissions. We answer three main research questions: 1) When do customers... View Details
- July 2023 (Revised October 2024)
- Case
Revenue Recognition at Stride Funding: Making Sense of Revenues for a Fintech Startup
By: Paul M. Healy and Jung Koo Kang
The case explores the challenges of revenue recognition and financial reporting for Stride Funding (Stride), a fintech startup that has disrupted the student loan market. Stride leveraged proprietary machine learning and financial models to underwrite alternative... View Details
- 2023
- Book
Suharto's Cold War: Indonesia, Southeast Asia, and the World
By: Mattias Fibiger
After the murder of senior generals in the Indonesian army by elements of the country's communist party in 1965, General Suharto orchestrated the mass killing of some half a million leftists and fellow travelers. But his ambitions spanned far beyond perpetrating a... View Details
- July–August 2023
- Article
Case Study: How Should a Start-Up Cut Its Burn Rate?
By: Nitin Nohria, Katie Josephson, Sophia Wronsky and Elizabeth Rha
Tyler Smith, the founder and CEO of the enterprise software firm Puck.io, is facing a hard decision. Just three months earlier the company laid off 20% of its employees to reduce its burn rate amid growing economic uncertainty and a suddenly unattractive funding... View Details
- 2023
- Working Paper
The Party and Firm
By: Joris Mueller, Jaya Y. Wen and Cheryl Wu
This project documents the rise of the Chinese Communist Party’s influence on
firms in China over the last decade. We propose novel quantitative measures of Party
influence and present recent trends in those measures. We corroborate qualitative work
and find a sharp... View Details
- 2023
- Book
The State and Capitalism in China
By: Meg Rithmire, Margaret M. Pearson and Kellee S. Tsai
This element explains China's political economic evolution from state socialist economy to a reform era state capitalism model to a more politicized, risk management approach we call "party-state capitalism." We emphasize the internal and external sources of perceived... View Details
- June 2023
- Case
ByteDance: TikTok and the Trials of Going Viral in 2023
By: William C. Kirby, Noah B. Truwit and John P. McHugh
In March 2023, Chew, with an army of well-paid U.S. lobbyists and TikTok creators, descended on Washington. In his testimony, he planned to highlight the 150 million daily active American users on TikTok and how the platform had benefitted small business owners and... View Details
- June 2023
- Supplement
Roche: ESG and Access to Healthcare
By: George Serafeim
In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first ESG investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that... View Details
Keywords: ESG (Environmental, Social, Governance) Performance; Sustainable Finance; Growth Strategy And Execution; Sustainability Targets; Impact Evaluation; Healthcare Access; Healthcare Innovation; Healthcare Systems; Healthcare Operations; Finance; Strategy; Health Testing and Trials; Health Care and Treatment; Growth Management; Measurement and Metrics; Innovation Strategy; Corporate Social Responsibility and Impact; Health Industry; Pharmaceutical Industry; Switzerland; North America; Europe; Asia; Latin America; Africa